Leucegene is a Quebec-based team of multidisciplinary scientists, clinicians, economists and lawyers with the mission to change the treatment of acute myeloid leukemia using precision therapy approaches.

Leucegene team is now recruting

The Leucegene team is currently seeking highly motivated doctoral students with an experience and interest in cancer research, molecular biology or proteomics wishing to pursue graduate studies in Montréal.

We also have openings for post-doctoral positions in cancer research, molecular biology or proteomics and one position for a research fellow in hematology- Oncology.
Interested qualified candidates, please send your CV and cover letter at info@leucegene.ca.

Additional Project Support

Management Team

Guy Sauvageau – Executive Committee Leucegene

Josée Hébert – Executive Committee Leucegene

Anne Marinier – Executive Committee Leucegene

Sébastien Lemieux – Executive Committee Leucegene

Philippe Roux – Executive Committee Leucegene

Muriel Draoui – Project Manager Leucegene

Intellectual Property Protection

Julie Simard – Mercier – Intellectual Property Analyst IRICoR

IC’s platforms

Patrick Gendron – Bio-informatics

Christian Charbonneau – Bio-imaging

Raphaëlle Lambert – Genomics

Jean Duchaine – High-Throughput Screening

Collaborators

Paresh Vyas – Professor of Haematology Oxford University

Richard Simon  –  Biometric Research Branch National Institutes of Health

Contact Us

For questions or information: info@leucegene.ca

Guy Sauvageau
Project leader
Marcelle-Coutu Pavilion, office 1371
T + 514 343.7134
guy.sauvageau@umontreal.ca

Josée Hébert
Co-project leader
Hôpital Maisonneuve-Rosemont
T + 514 252.3404
josee.hebert@umontreal.ca

Main office addresses:

Postal address:
IRIC
P.O. Box 6128, Downtown Station
Montreal, QC, H3C 3J7
CANADA

Address for deliveries:
2950, Chemin de Polytechnique
Marcelle-Coutu Pavilion, Dock 20
Montreal, QC, H3T 1J4
CANADA

On-Campus address:
Marcelle-Coutu Pavilion
2950, chemin de Polytechnique

$12.8 million for Leucegene

Guy Sauvageau, Josée Hébert and the Leucegene team are awarded $12.8 million in funding from Genome Canada and Genome Quebec to continue their work on AML. Click here for more information.

 

Leucegene Team is now recruiting